"1"^^ . "Pharmacological treatment of patients with atrial fibrillation: The Present and (near) future"@en . "1212-4184" . . . "RIV/00023001:_____/10:00002244" . . . . "Krom\u011B klasick\u00FDch antiarytmik se hledaj\u00ED se nov\u00E9 zp\u016Fsoby \u00FA\u010Dinn\u011Bj\u0161\u00ED a bezpe\u010Dn\u011Bj\u0161\u00ED l\u00E9\u010Dby. Nejd\u00E1le je v\u00FDvoj antiarytmik III. skupiny, deriv\u00E1t\u016F amiodaronu. Bylo schv\u00E1leno pou\u017E\u00EDv\u00E1n\u00ED dronedaronu. Krom\u011B samotn\u00E9ho ovlivn\u011Bn\u00ED v\u00FDskytu FS se klade d\u016Fraz na sn\u00ED\u017Een\u00ED po\u010Dtu hospitalizac\u00ED, ikt\u016F, kardiovaskul\u00E1rn\u00ED morbidity a mortality. Je studov\u00E1na \u0159ada nov\u00FDch l\u00E9k\u016F ke kontrole rytmu. Velk\u00E9 nad\u011Bje se vkl\u00E1daly do mo\u017Enosti ovlivn\u011Bn\u00ED remodela\u010Dn\u00EDch zm\u011Bn, tzv. ?upstream? l\u00E9\u010Dby. Metaanal\u00FDzy studi\u00ED nalezly p\u0159\u00EDzniv\u00FD efekt ACE-inhibitor\u016F, blok\u00E1tor\u016F angiotenzinov\u00FDch receptor\u016F a statin\u016F. Rutinn\u00ED pod\u00E1v\u00E1n\u00ED t\u011Bchto prepar\u00E1t\u016F jen z indikace FS v\u0161ak nen\u00ED zat\u00EDm od\u016Fvodn\u011Bn\u00E9, snad s v\u00FDjimkou statin\u016F v prevenci postopera\u010Dn\u00EDch arytmi\u00ED."@cs . "CZ - \u010Cesk\u00E1 republika" . "Postgradu\u00E1ln\u00ED medic\u00EDna" . "12" . . "Pharmacological treatment of patients with atrial fibrillation: The Present and (near) future"@en . "Krom\u011B klasick\u00FDch antiarytmik se hledaj\u00ED se nov\u00E9 zp\u016Fsoby \u00FA\u010Dinn\u011Bj\u0161\u00ED a bezpe\u010Dn\u011Bj\u0161\u00ED l\u00E9\u010Dby. Nejd\u00E1le je v\u00FDvoj antiarytmik III. skupiny, deriv\u00E1t\u016F amiodaronu. Bylo schv\u00E1leno pou\u017E\u00EDv\u00E1n\u00ED dronedaronu. Krom\u011B samotn\u00E9ho ovlivn\u011Bn\u00ED v\u00FDskytu FS se klade d\u016Fraz na sn\u00ED\u017Een\u00ED po\u010Dtu hospitalizac\u00ED, ikt\u016F, kardiovaskul\u00E1rn\u00ED morbidity a mortality. Je studov\u00E1na \u0159ada nov\u00FDch l\u00E9k\u016F ke kontrole rytmu. Velk\u00E9 nad\u011Bje se vkl\u00E1daly do mo\u017Enosti ovlivn\u011Bn\u00ED remodela\u010Dn\u00EDch zm\u011Bn, tzv. ?upstream? l\u00E9\u010Dby. Metaanal\u00FDzy studi\u00ED nalezly p\u0159\u00EDzniv\u00FD efekt ACE-inhibitor\u016F, blok\u00E1tor\u016F angiotenzinov\u00FDch receptor\u016F a statin\u016F. Rutinn\u00ED pod\u00E1v\u00E1n\u00ED t\u011Bchto prepar\u00E1t\u016F jen z indikace FS v\u0161ak nen\u00ED zat\u00EDm od\u016Fvodn\u011Bn\u00E9, snad s v\u00FDjimkou statin\u016F v prevenci postopera\u010Dn\u00EDch arytmi\u00ED." . "258779" . "8"^^ . "N" . "[023178FB4598]" . . . . . "Farmakologick\u00E1 l\u00E9\u010Dba u pacient\u016F s fibrilac\u00ED s\u00EDn\u00ED: sou\u010Dasnost a (bl\u00EDzk\u00E1) budoucnost"@cs . "Basic options of treating patients with atrial fibrillation are heart rhythm control, chambers rate control and prevention of thromboembolic events. Rhythm control and rate control are equivalent treatment options, as shown in clinical studies so far, even in patients with heart failure. In practice, however, we can find groups of patients, in whom rhythm control is more beneficial or, vice versa, rate control is more beneficial. In addition to conventional anti-arrhythmics we are looking for new more effective and safer treatments options. Furthermost is the development of III group anti-arrhythmic drugs, amiodarone derivatives. Dronedarone use was approved. Emphasis on reducing the number of hospitalizations, strokes, cardiovascular morbidity and mortality is been made in addition to influencing the occurrence of atrial fibrillation. A number of new rhythm control drugs is been studied. Great hopes were inserted into the option of influencing remodeling changes, so-called ?upstream? treatment. Met"@en . . "5" . . "Farmakologick\u00E1 l\u00E9\u010Dba u pacient\u016F s fibrilac\u00ED s\u00EDn\u00ED: sou\u010Dasnost a (bl\u00EDzk\u00E1) budoucnost" . . "RIV/00023001:_____/10:00002244!RIV11-MZ0-00023001" . . . "Farmakologick\u00E1 l\u00E9\u010Dba u pacient\u016F s fibrilac\u00ED s\u00EDn\u00ED: sou\u010Dasnost a (bl\u00EDzk\u00E1) budoucnost" . "Farmakologick\u00E1 l\u00E9\u010Dba u pacient\u016F s fibrilac\u00ED s\u00EDn\u00ED: sou\u010Dasnost a (bl\u00EDzk\u00E1) budoucnost"@cs . "\u010Cih\u00E1k, Robert" . "1"^^ . . "atrial fibrillation; anti-arrhythmics; rhythm control; rate control; %22upstream treatment%22"@en .